Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost-Reference-Cited by-同舟云学术

Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost

Published:2000-02 Issue:2 Volume:19 Page:138-143
ISSN:0891-3668
Container-title:The Pediatric Infectious Disease Journal
language:en
Short-container-title:The Pediatric Infectious Disease Journal

Author:

ATKINS JANE T.,KARIMI PRAMEELA,MORRIS BRENDA H.,MCDAVID GEORGIA,SHIM SHARON

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference17 articles.

1. Epidemiology of Acute Lower Respiratory Disease in Children

2. Respiratory Syncytial Viral Infection in Infants with Congenital Heart Disease

3. Immunoprophylaxis and the Control of RSV Disease

4. Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin Prophylaxis

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review;The Journal of Infectious Diseases;2022-08-15

2. Effectiveness of Respiratory Syncytial Virus Immunoprophylaxis in Reducing Bronchiolitis Hospitalizations Among High-Risk Infants;American Journal of Epidemiology;2018-01-17

3. Production of intravenous human dengue immunoglobulin from Brazilian-blood donors;Brazilian Journal of Pharmaceutical Sciences;2013-12

4. Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations;Journal of the Pediatric Infectious Diseases Society;2013-03-21

5. Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis;PharmacoEconomics;2010-04